Physostigmine- and pilocarpine-containing product in ocular dose form 785564009
SNOMED CT code
SNOMED code | 785564009 |
---|---|
name | Physostigmine- and pilocarpine-containing product in ocular dose form |
status | active |
date introduced | 2019-07-31 |
fully specified name(s) | Product containing physostigmine and pilocarpine in ocular dose form (medicinal product form) |
synonyms | Physostigmine- and pilocarpine-containing product in ocular dose form |
attributes - group0 | |
Has manufactured dose form | Ocular dose form 385276004 |
Plays role | Antiglaucoma therapeutic role 773832000 |
attributes - group2 | |
Has active ingredient | Physostigmine 373347005 |
attributes - group1 | |
Has active ingredient | Pilocarpine 372895002 |
parents | |
children | Physostigmine and pilocarpine only product in ocular dose form 786272003 |
hierarchies | a selection of possible paths SNOMED CT Concept 138875005Pharmaceutical / biologic product 373873005 Medicinal product 763158003 Medicinal product categorized by disposition 766779001 Acetylcholine receptor agonist-containing product 420383004 Muscarinic receptor agonist-containing product 764138006 Pilocarpine-containing product 90356005 Physostigmine- and pilocarpine-containing product 398647006 Physostigmine- and pilocarpine-containing product in ocular dose form 785564009 SNOMED CT Concept 138875005 Pharmaceutical / biologic product 373873005 Medicinal product 763158003 Product manufactured as ocular dose form 440130005 Physostigmine-containing product in ocular dose form 771825000 Physostigmine- and pilocarpine-containing product in ocular dose form 785564009 SNOMED CT Concept 138875005 Pharmaceutical / biologic product 373873005 Medicinal product 763158003 Product manufactured as ocular dose form 440130005 Pilocarpine-containing product in ocular dose form 771958008 Physostigmine- and pilocarpine-containing product in ocular dose form 785564009 |
ancestors | sorted most to least specific
|
cpt crosswalks |
Thank you for choosing Find-A-Code, please Sign In to remove ads.